Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
AVITA Medical to Announce Second Quarter 2024 Financial Results
04:10pm, Thursday, 11'th Jul 2024
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
04:05pm, Monday, 01'st Jul 2024
VALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical Achieves Milestone with First Case Using RECELL GO
04:25pm, Wednesday, 05'th Jun 2024
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical Announces FDA Approval of RECELL GO
09:15am, Thursday, 30'th May 2024
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care manag
AVITA Medical to Host Investor Webinar Briefing
06:30pm, Thursday, 16'th May 2024
VALENCIA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care manag
AVITA Medical Reports First Quarter Financial Results
04:01pm, Monday, 13'th May 2024
VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care manag
AVITA Medical to Announce First Quarter 2024 Financial Results
05:05pm, Monday, 15'th Apr 2024
AVITA Medical will report first quarter 2024 financial results after the close on May 13, 2024, and host a webcast that day at 1:30 p.m. Pacific Time.
AVITA Medical Updates Expected First Quarter 2024 Revenue
05:11pm, Wednesday, 10'th Apr 2024
AVITA Medical updates expected Q1 2024 commercial revenue; reaffirms expectations for full-year 2024 revenue at lower end of previously provided guidance.
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
04:02pm, Thursday, 29'th Feb 2024
AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
09:00am, Thursday, 29'th Feb 2024
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical to Host Investor Webinar Briefing
09:01am, Friday, 23'rd Feb 2024
VALENCIA, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript
11:03pm, Thursday, 22'nd Feb 2024
AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
04:01pm, Thursday, 22'nd Feb 2024
VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
04:10pm, Thursday, 01'st Feb 2024
VALENCIA, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cell
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
04:01pm, Wednesday, 10'th Jan 2024
VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices
